Ceci F; Herrmann K; Castellucci P; Graziani T; Bluemel C; Schiavina R; Vollmer C; Droll S; Brunocilla E; Mazzarotto R; Buck AK; Fanti S, Erratum to: Impact of 11C-choline PET/CT on clinical decision making in recurrent prostate cancer: results from a retrospective two-centre trial., «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2014, 41, pp. 2359 - 2359 [Scientific article]
E. Palmerini; C. Nanni; M. Colangeli; A. Paioli; S. Fanti; M. Gambarotti; P. Picci; D. Donati; S. Ferrari, FDG PET/CT IN PATIENTS TREATED WITH NEOADJUVANT CHEMOTHERAPY FOR LOCALIZED BONE SARCOMAS, in: Annals of Oncology, 2014(atti di: ESMO 2014, MADRID, 26 - 30 Settembre 2014) [Poster]
Schiavina R;Concetti S;BRUNOCILLA E.;Nanni C;Borghesi M;Gentile G;Cevenini M;Bianchi L;Molinaroli E;Fanti S;Martorana G, First Case of F-FACBC PET/CT-Guided Salvage Retroperitoneal Lymph Node Dissection for Disease Relapse after Radical Prostatectomy for Prostate Cancer and Negative (11)C-Choline PET/CT: New Imaging Techniques May Expand Pioneering Approaches., «UROLOGY INTERNATIONAL», 2014, 92, pp. 242 - 245 [Scientific article]
Brunocilla E; Schiavina R; Nanni C; Borghesi M; Cevenini M; Molinaroli E; Vagnoni V; Castellucci P; Ceci F; Fanti S; Gaudiano C; Golfieri R; Martorana G, First case of 18F-FACBC PET/CT-guided salvage radiotherapy for local relapse after radical prostatectomy with negative 11C-Choline PET/CT and multiparametric MRI: New imaging techniques may improve patient selection., «ARCHIVIO ITALIANO DI UROLOGIA ANDROLOGIA», 2014, 86, pp. 239 - 240 [Scientific article]Open Access
Bengel F; Bonfiglioli R; Fanti S., Highlights of the 26th EANM 2013 congress in Lyon: new horizons and further., «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2014, 41, pp. 792 - 805 [Scientific article]
Maurer AH; Elsinga P; Fanti S; Nguyen B; Oyen WJ; Weber WA, Imaging the folate receptor on cancer cells with 99mTc-etarfolatide: properties, clinical use, and future potential of folate receptor imaging., «THE JOURNAL OF NUCLEAR MEDICINE», 2014, 55, pp. 701 - 704 [Scientific article]
Ceci F; Herrmann K; Castellucci P; Graziani T; Bluemel C; Schiavina R; Vollmer C; Droll S; Brunocilla E; Mazzarotto R; Buck AK; Fanti S, Impact of 11C-choline PET/CT on clinical decision making in recurrent prostate cancer: results from a retrospective two-centre trial, «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2014, 41, pp. 2222 - 2231 [Scientific article]
Grassi I; Castellucci P; Nanni C; Ghedini P; Ambrosini V; Allegri V; Montini GC; Guidalotti PL; Fanti S, Incidentally detected increased FDG uptake in bowel and its correlation with hystopathological data: our experience in a case series study., «CURRENT RADIOPHARMACEUTICALS», 2014, 7, pp. 107 - 114 [Scientific article]
Chondrogiannis S; Marzola MC; Ferretti A; Grassetto G; Maffione AM; Rampin L; Fanti S; Giammarile F; Rubello D, Is the detection rate of 18F-choline PET/CT influenced by androgen-deprivation therapy?, «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2014, 41, pp. 1293 - 1300 [Scientific article]
Fanti, S., Nuclear medicine in urological cancers: what is new?, «FUTURE ONCOLOGY», 2014, 10, pp. 2061 - 2072 [Scientific article]
Lopci, Egesta; Grassi, Ilaria; Chiti, A; Nanni, C; Cicoria, Gianfranco; Toschi, Laura; Fonti, C; Lodi, Filippo; Mattioli, Sandro; Fanti, Stefano, PET radiopharmaceuticals for imaging of tumor hypoxia: a review of the evidence, «AMERICAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2014, 4, pp. 365 - 384 [Scientific article]
Nanni C.; Rossetti V.; Zompatori M.; Ambrosini V.; Montesi V.; Mascherini D.; Pettinato C.; Marzola MC.; Colletti PM.; Rubello D.; Fanti S., Performance of FDG PET/ceCT in the evaluation of patients with lung cancer, «BIOMÉDECINE & PHARMACOTHÉRAPIE», 2014, 68, pp. 219 - 223 [Scientific article]
Zamagni, Elena; Nanni, Cristina; Tacchetti, Paola; Pantani, Lucia; Marzocchi, Giulia; Zannetti, BEATRICE ANNA; Terragna, Carolina; Mancuso, Katia; Rocchi, S; Pezzi, Annalisa; Testoni, Nicoletta; Fanti, Stefano; Cavo, Michele, Positron emission tomography with computed tomography-based diagnosis of massive extramedullary progression in a patient with high-risk multiple myeloma., «CLINICAL LYMPHOMA MYELOMA & LEUKEMIA», 2014, 14, pp. 101 - 104 [Scientific article]
Pettinato C; Spezi E; Nanni C; Grassetto G; Monari F; Allegri V; Civollani S; Cima S; Zagni P; Mazzarotto R; Colletti PM; Rubello D; Fanti S, Pretherapeutic dosimetry in patients affected by metastatic thyroid cancer using 124I PET/CT sequential scans for 131I treatment planning., «CLINICAL NUCLEAR MEDICINE», 2014, 39, pp. 367 - 374 [Scientific article]
Piccardo A; Puntoni M; Lopci E; Conte M; Foppiani L; Sorrentino S; Morana G; Naseri M; Cistaro A; Villavecchia G; Fanti S; Garaventa A, Prognostic value of ¹⁸F-DOPA PET/CT at the time of recurrence in patients affected by neuroblastoma., «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2014, 41, pp. 1046 - 1056 [Scientific article]
